Spots Global Cancer Trial Database for intensity modulated radiotherapy
Every month we try and update this database with for intensity modulated radiotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen | NCT04340401 | Rectal Cancer | SHR-1210 Oxaliplatin Capecitabine Intensity modul... Total mesorecta... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
| Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy | NCT01185145 | Breast Cancer | Breast Brachyth... Intensity Modul... | 40 Years - | Rocky Mountain Cancer Centers | |
| Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen | NCT04340401 | Rectal Cancer | SHR-1210 Oxaliplatin Capecitabine Intensity modul... Total mesorecta... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
| Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer | NCT01340508 | Rectal Cancers. | Intensity Modul... | 21 Years - 90 Years | National University Hospital, Singapore | |
| Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck | NCT01491139 | Carcinoma, Squa... | olaparib cisplatin Intensity Modul... | 18 Years - | University College, London | |
| Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer | NCT03224000 | Malignant Neopl... Oropharyngeal C... | Modified Barium... Swallowing Ques... Symptom Questio... Video-Strobe Pr... MRI Guided Inte... Standard-of-Car... Intensity Modul... | 18 Years - | M.D. Anderson Cancer Center | |
| Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | NCT00508703 | Uterine Cancer Cervical Cancer Endometrial Can... | Intensity Modul... CT Scan | - | M.D. Anderson Cancer Center | |
| Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT) | NCT01854554 | Brain Cancer | IMPT IMRT Cognitive Tests Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC. | NCT03196843 | Head and Neck S... | Raltitrexed Intensity Modul... | 65 Years - | The First Affiliated Hospital of Dalian Medical University | |
| Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy | NCT03647527 | Nasopharyngeal ... | 18 Years - | Zhejiang Cancer Hospital | ||
| Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer | NCT01340508 | Rectal Cancers. | Intensity Modul... | 21 Years - 90 Years | National University Hospital, Singapore | |
| Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer | NCT05388773 | Oropharynx Canc... | therapeutic con... laboratory biom... quality-of-life... intensity-modul... Cisplatin Carboplatin | 18 Years - | University of Pittsburgh | |
| Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients | NCT03411954 | Nasopharyngeal ... | 18 Years - 75 Years | Zhejiang Cancer Hospital | ||
| Stereotactic Radiotherapy and Image-guided Intensity Modulated Radiotherapy for Spinal Metastatic Tumors | NCT03963713 | Radiotherapy Spine Metastase... Radiosurgery | Stereotactic ra... Conventionally-... | 18 Years - 80 Years | Peking University Third Hospital | |
| Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer | NCT02864849 | Rectal Cancer | Oxaliplatin Capecitabine Intensity modul... Total mesorecta... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | |
| Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | NCT00508703 | Uterine Cancer Cervical Cancer Endometrial Can... | Intensity Modul... CT Scan | - | M.D. Anderson Cancer Center | |
| Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer | NCT00593866 | Pancreatic Canc... | INTENSITY MODUL... Gemcitabine | 18 Years - | University of Michigan Rogel Cancer Center | |
| Protons vs. Photons for High-risk Prostate Cancer | NCT05350475 | Prostate Cancer Radiotherapy Si... | Proton therapy Photon therapy | 18 Years - | University of Aarhus | |
| Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer | NCT04405206 | Rectum Cancer | Oxaliplatin Capecitabine intensity modul... DRE-Endoscopy-M... Nonoperative Ma... Local excision Total Mesorecta... Quality of Life... | 18 Years - 85 Years | Peking University Cancer Hospital & Institute | |
| The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma | NCT02116231 | Effects of Chem... | Concurrent chem... Intensity modul... | 18 Years - 70 Years | Cancer Hospital of Guangxi Medical University | |
| Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy | NCT01185132 | Breast Cancer | accelerated par... accelerated par... | 40 Years - | Rocky Mountain Cancer Centers | |
| Study of Radiation Therapy in Combination With Xeloda, for Initially Metastatic, Low and Middle Rectal Cancer | NCT03634202 | Rectal Cancer Metastasis Radiotherapy | IMRT + oral che... | 18 Years - | Institut Cancerologie de l'Ouest | |
| Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT | NCT01212354 | Locally Advance... | Radiotherapy | 18 Years - 70 Years | Technical University of Munich | |
| A Study of IMRT in Primary Bone and Soft Tissue Sarcoma | NCT02520128 | Soft Tissue Sar... Ewing Sarcoma Bone Sarcoma Chordoma | Intensity modul... | 16 Years - | University College, London | |
| Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT) | NCT01854554 | Brain Cancer | IMPT IMRT Cognitive Tests Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer | NCT04405206 | Rectum Cancer | Oxaliplatin Capecitabine intensity modul... DRE-Endoscopy-M... Nonoperative Ma... Local excision Total Mesorecta... Quality of Life... | 18 Years - 85 Years | Peking University Cancer Hospital & Institute | |
| Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT | NCT01212354 | Locally Advance... | Radiotherapy | 18 Years - 70 Years | Technical University of Munich | |
| IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma | NCT03068936 | Nasopharyngeal ... | Intensity modul... Cisplatin | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen | NCT04340401 | Rectal Cancer | SHR-1210 Oxaliplatin Capecitabine Intensity modul... Total mesorecta... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
| Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma | NCT05097209 | Nasopharyngeal ... | Camrelizumab Gemcitabine Induction Cispl... intensity-modul... Concurrent cisp... | 18 Years - 70 Years | Guilin Medical University, China | |
| Accelerated Partial Breast Irradiation With 3D-CRT and IMRT | NCT02003560 | Breast Cancer Radiation Toxic... Side Effects | accelerated par... | 40 Years - | National Institute of Oncology, Hungary | |
| Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule | NCT02257827 | Prostate Cancer | IMRT | 18 Years - 75 Years | Marilia Medicine School | |
| IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma | NCT03068936 | Nasopharyngeal ... | Intensity modul... Cisplatin | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma | NCT04895345 | Nasopharyngeal ... | TQB2450 Intensity modul... | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer | NCT00527631 | Ovarian Cancer | whole abdomen i... | 18 Years - 75 Years | Heidelberg University | |
| Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses | NCT05114707 | Nasal Cavity Ca... Paranasal Sinus... Camrelizumab Induction Chemo... Intensity Modul... Concurrent Chem... | camrelizumab | 18 Years - 65 Years | Sun Yat-sen University | |
| Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck | NCT01491139 | Carcinoma, Squa... | olaparib cisplatin Intensity Modul... | 18 Years - | University College, London | |
| A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation | NCT00667888 | Prostate Cancer | Conventional Fr... Hypofractionate... | - | M.D. Anderson Cancer Center | |
| Whole Brain Radiation Using IMRT for Patients With Brain Metastases | NCT02753790 | Neoplasm Metast... Central Nervous... | Intensity Modul... | 18 Years - | New Mexico Cancer Care Alliance | |
| Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC. | NCT03196843 | Head and Neck S... | Raltitrexed Intensity Modul... | 65 Years - | The First Affiliated Hospital of Dalian Medical University | |
| COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer | NCT03241537 | Prostate Neopla... | Intensity modul... | 20 Years - | Samsung Medical Center | |
| A Study of LY3200882 in Participants With Solid Tumors | NCT02937272 | Solid Tumor | LY3200882 LY3300054 Gemcitabine nab-Paclitaxel Cisplatin Intensity Modul... | 18 Years - | Eli Lilly and Company |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
